These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 3041329)

  • 1. [Pathophysiology of hyperprolactinemia in breast cancer].
    Holtkamp W; Wuttke W; Nagel GA; Michel U; Rauschecker H
    Onkologie; 1988 Apr; 11(2):86-103. PubMed ID: 3041329
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Plasma-prolactin concentrations in breast cancer at various stages, in mastopathy and other malignant tumors].
    Holtkamp W; von Heyden D; Rauschecker H; Nagel GA
    Schweiz Med Wochenschr; 1983 Oct; 113(41):1513-20. PubMed ID: 6635641
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Importance of serum prolactin determination in metastatic breast cancer patients.
    Mujagić Z; Mujagić H
    Croat Med J; 2004 Apr; 45(2):176-80. PubMed ID: 15103755
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Metergoline in hyperprolactinemic breast cancer: a phase II study].
    Holtkamp W; Nagel GA
    Onkologie; 1986 Oct; 9(5):245-8. PubMed ID: 3101016
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Stimulation of prolactin secretion with thyroliberin (TRH). In vivo and in vitro studies of metastatic breast cancer].
    Holtkamp W; Nagel GA
    Onkologie; 1988 Dec; 11(6):267-71. PubMed ID: 3149403
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Antipsychotic-drug-induced hyperprolactinemia: physiopathology, clinical features and guidance].
    Besnard I; Auclair V; Callery G; Gabriel-Bordenave C; Roberge C
    Encephale; 2014 Feb; 40(1):86-94. PubMed ID: 23928066
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Macroprolactinemia in women with hyperprolactinemia: a 10-year follow-up.
    Radavelli-Bagatini S; Lhullier FL; Mallmann ES; Spritzer PM
    Neuro Endocrinol Lett; 2013; 34(3):207-11. PubMed ID: 23685418
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pituitary production of prolactin and prolactin-suppressing drugs.
    Tansey MJ; Schlechte JA
    Lupus; 2001; 10(10):660-4. PubMed ID: 11721691
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hyperprolactinemia is an indicator of progressive disease and poor prognosis in advanced breast cancer.
    Holtkamp W; Nagel GA; Wander HE; Rauschecker HF; von Heyden D
    Int J Cancer; 1984 Sep; 34(3):323-8. PubMed ID: 6480153
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Defective dopaminergic regulation of prolactin secretion in patients with hyperprolactinemia.
    Serri O; Beauregard H; Somma M; Comtois R; Jilwan N; Hardy J
    Clin Invest Med; 1988 Dec; 11(6):387-91. PubMed ID: 3229037
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prediction of recurrence in operable breast cancer by postoperative changes in prolactin secretion.
    Lissoni P; Barni S; Cazzaniga M; Ardizzoia A; Rovelli F; Tancini G; Brivio F; Frigerio F
    Oncology; 1995; 52(6):439-42. PubMed ID: 7478427
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Biological response modifiers of cancer-related neuroendocrine disorders: efficacy of the long-term dopaminergic agonist cabergoline in the treatment of breast cancer-induced hyperprolactinemia.
    Lissoni P; Vaghi M; Pescia S; Rovelli F; Ardizzola A; Valtulina F; Malugani F; Gardani G; Tancini G
    J Biol Regul Homeost Agents; 2004; 18(3-4):291-4. PubMed ID: 15786695
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A study of surgical psychoncology in breast cancer: perioperative variation of prolactin serum levels in women with operable breast cancer in relation to their maternal psychological behaviour.
    Messina G; Lissoni P; Brivio F; Rovelli F; Fumagalli L; Bartolacelli E; Mazza U; Colombo E; Bertoglio A
    In Vivo; 2008; 22(6):845-8. PubMed ID: 19181018
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Catecholamines and pituitary function. VI. Effect of different dopamine doses on TRH-induced prolactin release in women with pathological hyperprolactinemia.
    Nicoletti I; Ambrosi F; Pagliacci MC; Pelicci G; Giammartino C; Maggio D; Fedeli L; Filipponi P
    Horm Metab Res; 1987 Mar; 19(3):125-9. PubMed ID: 3106177
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A study of pineal-prolactin interaction: prolactin response to an acute melatonin injection in patients with hyperprolactinemia.
    Lissoni P; Mainini E; Mazzi C; Cattaneo G; Barni S
    J Endocrinol Invest; 1990 Feb; 13(2):85-9. PubMed ID: 2329263
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The favorable prognostic significance of surgery-induced hyperprolactinemia in node-positive breast cancer patients: ten-year disease-free survival results.
    Bignami A; Lissoni P; Brivio F; Galbiati F; Pescia S; Messina G; Frontini L; Meregalli S; Gardani GS
    Int J Biol Markers; 2005; 20(1):60-4. PubMed ID: 15832774
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [The reaction of the hypophysis to thyroliberin and metoclopramide in women with hyperprolactinemia].
    Tkachenko NN; Potin VV; Beskrovnyĭ SV; Nosova LG
    Probl Endokrinol (Mosk); 1990; 36(2):35-40. PubMed ID: 2114023
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Importance of macroprolactinemia in hyperprolactinemia.
    Kasum M; Pavičić-Baldani D; Stanić P; Orešković S; Sarić JM; Blajić J; Juras J
    Eur J Obstet Gynecol Reprod Biol; 2014 Dec; 183():28-32. PubMed ID: 25461348
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Catecholamines and pituitary-function. V. Effect of low-dose dopamine infusion on basal and gonadotropin-releasing hormone stimulated gonadotropin release in normal cycling women and patients with hyperprolactinemic amenorrhea.
    Nicoletti I; Ambrosi F; Giammartino C; Fedeli L; Mannarelli C; Filipponi P
    Horm Metab Res; 1986 Jul; 18(7):479-84. PubMed ID: 3091473
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Plasma levels of parathyroid hormone-related peptide are elevated in hyperprolactinemia and correlated to bone density status.
    Stiegler C; Leb G; Kleinert R; Warnkross H; Ramschak-Schwarzer S; Lipp R; Clarici G; Krejs GJ; Dobnig H
    J Bone Miner Res; 1995 May; 10(5):751-9. PubMed ID: 7639111
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.